Pharmavite Participates In ERSP Forum

New York, NY – December 13, 2005 – The Electronic Retailing Self-Regulation Program (ERSP) announced that Pharmavite LLC (Pharmavite), marketers of the Nature Made® Cholest-Off® Dietary Supplement (Cholest-Off), has substantiated general performance and establishment claims, and has voluntarily agreed to make more conspicuous disclosures in its advertising. The marketer’s advertising was reviewed pursuant to ERSP’s ongoing monitoring program.

ERSP, the electronic direct-response industry’s self-regulatory forum supervised by the National
Advertising Review Council (NARC), reviewed core claims that include:

“Cholest-Off’s proprietary blend can reduce cholesterol up to 24% on average in just 30 days.”
“…contains ingredients that are clinically proven to reduce cholesterol safely and naturally.”
“I began to take your product and within 28 days my cholesterol dropped 30 points!”

ERSP determined that the clinical data provided by Pharmavite provided a reasonable basis for its establishment and testimonial claims for Cholest-Off, as well as the quantified claim to “reduce cholesterol up to 24% on average in just 30 days.” ERSP noted, as well, that the scientific literature provided by Pharmavite demonstrated that its claim concerning the phytonutrient comparison to lettuce and corn was appropriate. ERSP also appreciates the marketer’s willingness to include more conspicuous disclosures regarding the typical range of performance that consumers may expect from taking the product.

Pharmavite, in its response to ERSP’s findings, said it “…appreciates the opportunity to participate in the ERSP self-regulatory process. We are pleased that the ERSP has determined that the core performance, establishment, and testimonial claims made for Nature Made® CholestOff® are substantiated… Pharmavite is a strong supporter of the voluntary advertising regulation process and is appreciative of the ERSP’s important role in that process, and of the ERSP’s thorough review of the detailed scientific evidence submitted in support of claims made for CholestOff.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

NAD Finds Certain Claims for Mott’s Fruit Flavored Snacks Supported or Outside NAD’s Jurisdiction; Recommends General Mills Discontinue or Modify Other Claims

New York, NY – November 25, 2024 – The National Advertising Division recommended that General Mills discontinue or modify certain express and implied claims regarding the fruit and vegetable content of Mott’s Fruit Flavored Snacks and the nutritional benefits of those ingredients.

Read the Decision Summary
Decision

In National Advertising Division Challenge, Drip Hydration Voluntarily Discontinues Claims for its Ketamine IV Therapy

New York, NY – November 22, 2024 – Following a challenge brought by the National Advertising Division as part of its routine monitoring program, Drip Hydration voluntarily discontinued advertising claims for its Drip Hydration Ketamine IV Therapy.

Read the Decision Summary
Decision

NAD Finds Patented and Safety Claims for POOPH’s Pet Odor & Stain Eliminator Supported; Recommends Other Claims Be Modified or Discontinued

New York, NY – November 21, 2024 – The National Advertising Division determined that Ikigai supported patented and safety claims for their POOPH Pet Odor & Stain Eliminator, but recommended that other claims, including claims that POOPH eliminates odors and strains, be discontinued.

Read the Decision Summary
Decision

National Advertising Division Recommends SharkNinja Discontinue Certain Best Deep Carpet Cleaning Claims

New York, NY – November 19, 2024 – BBB National Programs’ National Advertising Division recommended that SharkNinja discontinue the claim “The Best Deep Carpet Cleaning Among Full-Sized Deep Carpet Cleaners** Based on ASTM F2828 vs. full-sized carpet cleaners above 14 lbs.”     

Read the Decision Summary